855181-45-2

Upstream product

• 637354-71-3 allyl 3-O-dodecyl-α-D-glucopyranoside 
• 1125-88-8 benzaldehyde dimethyl acetal 

Downstream Products

• 855181-48-5 allyl 4,6-O-benzylidene-3-O-dodecyl-2-O-{(R)-3-[(4-methoxybenzyl)oxy]tetradecyl}-α-D-glucopyranoside 
• 855181-52-1 2-hydroxyethyl 4,6-O-benzylidene-3-O-dodecyl-2-O-{(R)-3-[(4-methoxybenzyl)oxy]tetradecyl}-α-D-glucopyranoside 
• 855181-62-3 2-[bis(allyloxy)phosphoryloxy]ethyl 4,6-O-benzylidene-3-O-dodecyl-2-O-[3-oxotetradecyl]-α-D-glucopyranoside 
• 855181-59-8 2-[bis(allyloxy)phosphoryloxy]ethyl 4,6-O-benzylidene-3-O-dodecyl-2-O-[(R)-3-hydroxytetradecyl]-α-D-glucopyranoside 
• 855181-56-5 2-[bis(allyloxy)phosphoryloxy]ethyl 4,6-O-benzylidene-3-O-dodecyl-2-O-{(R)-3-[(4-methoxybenzyl)oxy]tetradecyl}-α-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of lipid a analogues containing glucose instead of glucosamine and their LPS-antagonistic activities

Lipid A analogues containing glucose in substitution for glucosamine on the reducing end were synthesized, and the inhibitory activities on LPS-induced TNFα production (LPS-antagonistic activity) in vitro using human whole blood cells were measured. The I